Today’s Best Market Rumors (7/16/2012) GlaxoSmithKline Buys Human Genome Sciences
Updated throughout the day on the 24/7 Wall St. Wire: GlaxoSmithKline (NYSE: GSK) will buy Human Genome Sciences (NASDAQ: HGSI) for $2.8 billion. (Reuters) The Justic Department and HSBC (NYSE: HBC) are close to…